cancer - 医索

SMALL CELLLUNG CANCER -CURRENT STANDARD AND FUTURE OPPORTUNITIES（KAUSHAL）

医客学院 - 会议报告集

What tests are must-haves in lung cancer diagnostic today,and what's next for tomorrow（PAUL）

医客学院 - 会议报告集

17个NK细胞抗肿瘤靶点

NK细胞表面表达的主要受体很多，包括细胞因子相关、自身免疫识别相关、靶向杀伤相关等。随着NK细胞疗法向临床推进，不同靶点选择的优缺点对候选产品的影响也是显著的。增强对肿瘤细胞的靶向性是NK细胞疗法的关键要点之一。Cancer Letters.....

学术资讯 - 临床研究

大规模研究揭示：常喝牛奶，与中国人癌症风险升高有关，尤其是肝癌和乳腺癌

2022年5月，英国牛津大学、中国医学科学院和北京大学的研究人员合作，在 BMC Medicine 期刊发表了题为：Dairy consumption and risks of total and site-specific cancers in Chinese adults: an 11-year prospective study of .....

学术资讯 - 临床研究

immunosurveillance in clinical cancer management

医客学院

LBA73 Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC

医客学院 - 会议报告集

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

医客学院

Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET) a phase II study

医客学院

A Phase 3, Randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04)

医客学院

LBA17 Adjuvant abemaciclib plus endocrine therapy for HR , HER2-, high-risk early breast cancer Results from a preplanned monarchE overall survival interim analysis, including 5-year eff

医客学院 - 会议报告集